📌 Key Takeaways
- Topic: How to Choose a Silica Manufacturer: Capacity, Quality Control and Certifications
- Keywords: anti caking agent silica
- Published: 2026-11-20 05:46:27
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Tetraethyl Orthosilicate? Properties, Uses and Role in Silica Synthesis
- Silica as a Carrier: Converting Liquids into Free-Flowing Powders
- 32. Voicu S.N.P., Dinu D., Sima C., Hermenean A., Ardelean A., Codrici E., Stan M.S., Zărnescu O., Dinischiotu A. Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line. Int. J. Mol. Sci. 2015;16:29398-29416. doi: 10.3390/ijms161226171. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
- Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
- 42. Ortega E., Ruiz M.A., Peralta S., Russo G., Morales M.E. Improvement of mesoporous silica nanoparticles: A new approach in the administration of NSAIDS. J. Drug Deliv. Sci. Technol. 2020;58:101833. doi: 10.1016/j.jddst.2020.101833. [ DOI ] [ Google Scholar ]
- What Is Diatomaceous Earth? Composition, Grades and Common Uses
- If you're looking to eat DE for the health benefits, we suggest starting with a single teaspoon a day. Simply mix it with a glass of water, juice or a smoothie. After 1 -2 weeks you can build up to a tablespoon a day if you want to grow the effects. Taking DE is generally more effective when done separately from other foods. When taken with food, the absorptive properties of DE are used to take in the nutrients of the food, rather than any toxins in your body. This lessens the effect of both the diatomaceous earth and your meal. The same is true of medications. If you are taking regular medications, we would inspire you to consult with your healthcare provider before taking DE.
- What Is a Low CTE Filler? Why Fused and Spherical Silica Are Preferred
- where M t is the volume of drug released at time t; M 0 is the opening amount of drug; D is the diffusion coefficient in the matrix; and h is the thickness of the system.
Matting Agent Supplier: How to Choose the Right Silica Matting Agent Partner
What is silica (SiO₂)?
hydrated silica
What is the difference between fumed silica and precipitated silica?
MSNs are also appropriate for pulmonary drug delivery. Inhalation is an attractive route of administration since the application is non-invasive and patient-friendly [ 18 ]. However, the rapid mucociliary clearance and the mucus hurdle complicate the intake of the API and are obstacles to be overcome [ 18, 25 ]. The mesoporous drug delivery systems may be really helpful in the treatment of lung diseases, as they can passively accumulate in the alveoli [ 25, 56, 72 ]. The passive accumulation is due to their small size, while the sizable surface area, high vascularity, and vascular permeability of the lungs enhance the process [ 56 ]. Furthermore, targeted treatment of tumors or inflamed cells can also be implemented with the functionalization of their surface [ 56, 72 ]. MSNs are typically delivered to the lungs in powder form with dry powder inhalers or suspended in liquid droplets with a nebulizer [ 56 ].
What drives silica raw material prices?
silica for UV adhesive MSNs are SiO 2 nanoparticles [ 2 ] with a pore diameter between 2 and 50 nm [ 3, 4 ] and with a total diameter of a maximum of 1 µm. Their use in drug delivery dates to the early 1990s when they were synthesized for various scientific applications [ 5 ]. The material known as mesoporous silica was discovered by Mobil Oil Corporation in 1992 [ 6 ]. Their first drug delivery application was demonstrated in 2001 when MCM-41 silica was used to release ibuprofen [ 7 ]. Since then, MSNs have become an increasingly popular drug delivery system due to their advantageous properties and have been typically recognized as secure (GRAS) by the FDA. Tiny SNPs have been approved for human clinical imaging studies, setting the stage for their use in clinical applications of drug delivery. The number of related research activities is continuously increasing each year, expanding their role in cancer treatment, gene delivery, and oral illness therapy [ 5 ]. Their pore size is located between microporous and macroporous systems. They can be used in diverse shapes (sphere, cube, ellipsoid, rod) and sizes, with different pore sizes and pore structures [ 2, 3, 4, 8, 9, 10 ]. They have a high degree of stability [ 8 ] and a rigid framework, which results in resistance to temperature, pH, enzymatic degradation, and mechanical force [ 4 ]. Thanks to the large number of pores, they have a massive particular surface region (approx. 700-1300 m 2 /g) and pore volume (approx. 0.5-1.5 cm 3 /g), which enables effective adsorption of diverse molecules [ 2, 3, 4, 8, 9, 10 ]. By changing the pore size distribution, the range of adsorbable molecules can be controlled [ 3 ], which also lets separation based on size exclusion, which means selective adsorption of molecules of certain sizes. Depending on the size of the pores, tiny molecules together with high molecular weight proteins can be transported into the pores [ 8 ]. In addition, chemical separation is also possible if the surface of the pores is coated with specific functional groups [ 4 ], which enables the separation of the APIs according to their structure [ 4 ]. Such modifications may include the setting of hydrophilicity/hydrophobicity of the surface, depending on whether the adsorption of hydrophobic or hydrophilic molecules is targeted [ 4 ]. By inserting different functional groups, the surface charge can also be controlled so that certain molecules will bind more efficiently. MSNs have a negative surface charge in biological environments, which promotes the electrostatic adsorption of positively charged APIs in the pores [ 10 ]. Moreover, the biological markers attached to the surface of the nanoparticles enable the drug-carrying system to deliver the API in a tissue-specific manner [ 2, 4, 8, 9, 10 ]. A substantial problem is the premature release of the API from the pores during transport [ 4, 8 ], which can be solved by utilizing gatekeepers that respond to special stimuli and keep the pores closed until the stimulus [ 2, 4, 8 ]. In this way, controlled drug delivery and stimuli-responsive release can be achieved [ 2, 4, 9 ]. The drug release could be triggered by temperature, pH, redox potential, light, enzymes, magnetic field, or different ligands [ 4, 8, 11 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.